BioAge Labs (BIOA) Market Capitalization (2024 - 2026)

BioAge Labs has disclosed Market Capitalization across 3 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 657.79% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 657.79% YoY), while the FY2025 annual figure was $494.6 million, up 696.42% from the prior year.
• Market Capitalization came in at $1.1 billion for Q2 2026 at BioAge Labs, up from $776.3 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.1 billion in Q2 2026 to a low of $62.1 million in Q4 2024.
• Average Market Capitalization over 3 years is $377.7 million, with a median of $179.4 million recorded in 2025.
• The largest YoY upside for Market Capitalization was 696.42% in 2025 against a maximum downside of 190.01% in 2025.
• Over 3 years, Market Capitalization stood at $62.1 million in 2024, then surged by 696.42% to $494.6 million in 2025, then jumped by 126.84% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $1.1 billion in Q2 2026, $776.3 million in Q1 2026, and $494.6 million in Q4 2025.